Virtus ETF Advisers LLC Agios Pharmaceuticals, Inc. Transaction History
Virtus ETF Advisers LLC
- $234 Million
- Q4 2024
A detailed history of Virtus ETF Advisers LLC transactions in Agios Pharmaceuticals, Inc. stock. As of the latest transaction made, Virtus ETF Advisers LLC holds 9,160 shares of AGIO stock, worth $295,959. This represents 0.13% of its overall portfolio holdings.
Number of Shares
9,160
Previous 7,042
30.08%
Holding current value
$295,959
Previous $312,000
3.85%
% of portfolio
0.13%
Previous 0.15%
Shares
29 transactions
Others Institutions Holding AGIO
# of Institutions
243Shares Held
59.9MCall Options Held
270KPut Options Held
332K-
Farallon Capital Management LLC San Francisco, CA5.67MShares$183 Million0.99% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.63MShares$182 Million0.0% of portfolio
-
Black Rock Inc. New York, NY4.86MShares$157 Million0.0% of portfolio
-
Bellevue Group Ag Kuesnacht, V83.52MShares$114 Million2.3% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD2.42MShares$78.3 Million0.01% of portfolio
About AGIOS PHARMACEUTICALS, INC.
- Ticker AGIO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 54,818,000
- Market Cap $1.77B
- Description
- Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and ...